SILINGARDI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 8.341
EU - Europa 4.318
AS - Asia 3.916
SA - Sud America 513
Continente sconosciuto - Info sul continente non disponibili 251
AF - Africa 105
OC - Oceania 27
Totale 17.471
Nazione #
US - Stati Uniti d'America 8.146
IT - Italia 1.295
GB - Regno Unito 1.134
SG - Singapore 1.093
CN - Cina 1.090
SE - Svezia 453
HK - Hong Kong 419
BR - Brasile 370
VN - Vietnam 366
DE - Germania 273
FI - Finlandia 245
UA - Ucraina 232
TR - Turchia 220
FR - Francia 192
BD - Bangladesh 189
RU - Federazione Russa 183
IN - India 114
KR - Corea 109
CA - Canada 86
BG - Bulgaria 73
ID - Indonesia 53
AR - Argentina 44
NL - Olanda 43
MX - Messico 40
MY - Malesia 32
IQ - Iraq 31
ES - Italia 29
ZA - Sudafrica 29
PK - Pakistan 28
CO - Colombia 27
PL - Polonia 26
AU - Australia 24
JP - Giappone 24
EC - Ecuador 22
SA - Arabia Saudita 21
BZ - Belize 19
CL - Cile 18
IE - Irlanda 18
RO - Romania 18
CZ - Repubblica Ceca 17
BE - Belgio 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
PH - Filippine 14
AT - Austria 13
CR - Costa Rica 13
KE - Kenya 13
NP - Nepal 13
MA - Marocco 12
VE - Venezuela 12
ET - Etiopia 11
JM - Giamaica 10
LT - Lituania 10
EG - Egitto 9
TH - Thailandia 9
CH - Svizzera 8
DZ - Algeria 7
EU - Europa 7
TN - Tunisia 7
UZ - Uzbekistan 7
HN - Honduras 6
HU - Ungheria 6
JO - Giordania 6
KZ - Kazakistan 6
PE - Perù 6
PY - Paraguay 6
TW - Taiwan 6
AZ - Azerbaigian 5
DK - Danimarca 5
GE - Georgia 5
IL - Israele 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EE - Estonia 4
MD - Moldavia 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
CM - Camerun 3
KG - Kirghizistan 3
MK - Macedonia 3
PR - Porto Rico 3
SV - El Salvador 3
AN - Antille olandesi 2
GT - Guatemala 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 17.206
Città #
Santa Clara 857
Southend 778
Ashburn 754
Singapore 674
Fairfield 493
Chandler 455
San Jose 435
Jacksonville 434
Hong Kong 399
Council Bluffs 389
Hefei 380
Woodbridge 320
Dearborn 319
Houston 244
Wilmington 226
Nyköping 212
Beijing 205
Ann Arbor 203
Cambridge 192
Helsinki 164
Seattle 163
London 159
Los Angeles 157
Izmir 113
Milan 110
Ho Chi Minh City 108
The Dalles 107
New York 100
Buffalo 99
Princeton 86
Chicago 82
Hanoi 82
Seoul 80
San Diego 73
Eugene 71
Sofia 71
Columbus 67
Rome 67
Des Moines 63
Lauterbourg 57
Moscow 51
Jakarta 45
Dong Ket 44
Falls Church 39
Shanghai 34
Dallas 33
São Paulo 32
Bremen 31
Orem 29
Salt Lake City 27
Munich 26
Naples 26
Turin 25
Phoenix 24
Da Nang 22
Redwood City 21
Montreal 20
Belize City 19
Chennai 19
Tokyo 19
Toronto 19
Modena 18
Bari 17
Frankfurt am Main 17
Norwalk 17
Palermo 17
Brussels 16
Guangzhou 16
Brooklyn 15
Mexico City 15
Baghdad 14
Johannesburg 14
Verona 14
Warsaw 14
Bologna 13
Brno 13
Buraidah 13
Dublin 13
Falkenstein 13
Ottawa 13
Saint Petersburg 13
San Mateo 13
Tampa 13
Turku 13
Washington 13
Boston 12
Florence 12
Nanjing 12
Saint Louis 12
Atlanta 11
Boardman 11
Denver 11
Kunming 11
Philadelphia 11
Elk Grove Village 10
Haiphong 10
Madrid 10
North Bergen 10
Rio de Janeiro 10
San Francisco 10
Totale 11.163
Nome #
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 796
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 580
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 494
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 395
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 356
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 350
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 325
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 320
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 317
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 317
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL) 315
Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting 309
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: The Gruppo Italiano per lo Studio dei Linfomi Experience 307
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 304
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL 302
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer 298
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME 294
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia 292
A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma 291
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 285
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 277
HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL) 272
Hereditary risk of breast cancer: not only brca 259
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin 258
Comment on "Cancer genetic counselling' by P.!Mandich et al. (Ann Oncol 2005; 16: 171) 256
Bone marrow infiltration in Hairy cell leukemia after interferon therapy detected by magnetic resonance imagin 256
Alimentazione e tumori II. Le vitamine 254
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 253
Prevention of cisplatin induced vomiting in patients with cancer. A pilot study with a multiagent protocol 252
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS 251
Validation of the international prognostic index in working formulation group a low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo studio dei linfomi registry. 250
Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study 249
Leucemia e tricoleucociti: studio clinico patologico di 30 casi 245
Detection of bone marrow involvement in patients with cancer 244
Hodgkin's disease prognosis: a directly predictive equation 243
Trapianto di midollo osseo nelle aplasie midollari. 241
Profilassi del vomito nei pazienti affetti da linfoma non-Hodgkin trattati con il protocollo ProMECE-CytaBOM. Risultati preliminari di uno studio clinico controllato 240
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety 239
Usefulness of breast MRI in a patient with genetic risk 235
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 231
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form 228
Screening clinico, mammografico e genetico del carcinoma mammario ereditario 225
Studio clinico immunologico di sei casi di morbo di Behcet 224
Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) 219
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 212
Alimentazione e tumori I. Considerazioni dietetiche generali: gli alimenti 210
Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: a multicenter study in non-splenectomized patients 210
Alimentazione e tumori III. Gli oligoelementi 207
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission 206
Istiocitosi maligna 204
Long term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian cooperative group for HCL 202
Utilità della Risonanza Magnetica Nucleare nello studio del midollo osseo di pazienti affetti da hairy Cell Leukemia 201
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades 200
The excretion of tryptophan metabolites in patients with different forms of haemoblastosis 197
PROMACE-CYTABOM VERSUS MACOP-B IN INTERMEDIATE AND HIGH-GRADE NHL - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL 187
Utilità diagnostica della risonanza magnetica nucleare in onco-ematologia 184
Gli interferoni in terapia antineoplastica 184
Ruolo attuale della chemioterapia nel carcinoma transizionale della vescica muscolo-invasivo 184
La chemioprevenzione del carcinoma mammario 178
Free from failure survival in Hodgkin's disease. Long term analysis of 148 cases treated with a MOPP modified protocol 177
Cancer Incidence in the Province of Modena. Cancer Incidence in Five Continents Vol.VII 176
REGIMEN-RELATED LIVER TOXICITY IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION 170
La strategia terapeutica del GISL nei linfomi non-Hodgkin 162
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN AND CISPLATIN (M-VEC) IN PATIENTS WITH LOCALLY ADVANCED TRANSITIONAL BLADDER-CANCER 161
La predisposizione genetica al cancro dell'ovaio. Individuazione e sorveglianza delle donne a rischio 151
Immunohistochemical labeling index in breast cancer after in vivo administration of bromodeoxiuridine 142
Emopoiesi extramidollare endotoracica in Morbo di Cooley dell'adulto 128
Biological and clinical featuresof BRCA1and BRCA2 related tumors 70
BrCa1 mutational analysis in a population of Italian women affected by hereditary breast or breast/ovarian cancer 20
Totale 17.471
Categoria #
all - tutte 58.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.107 0 0 111 129 40 105 72 64 149 73 223 141
2022/20231.403 123 130 109 125 180 238 18 131 173 24 58 94
2023/2024826 44 45 50 84 147 68 143 66 9 34 35 101
2024/20252.874 117 39 50 222 609 422 221 201 319 84 279 311
2025/20265.046 298 264 506 362 569 477 569 218 544 473 447 319
2026/2027668 249 343 76 0 0 0 0 0 0 0 0 0
Totale 17.471